Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AZN save search
Minimal Residual Disease Testing Global Markets and Technology Research Report 2023-2028: Charting Cancer Treatment Trajectories - The Role of MRD Explored
Published: 2023-08-25 (Crawled : 14:30) - prnewswire.com
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: -3.27%
H: 3.65%
C: 3.36%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 0.22%
H: 0.6%
C: 0.31%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: 0.19%
H: 0.25%
C: -0.28%
disease report cancer treatment research global technology
Global Autoimmune Treatment Market Soars to $288.32 Billion by 2028, Driven by a 7.72% CAGR from 2023
Published: 2023-08-25 (Crawled : 02:00) - prnewswire.com
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: -3.27%
H: 3.65%
C: 3.36%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: -4.14%
H: 5.37%
C: 4.39%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.67%
H: 0.37%
C: 0.26%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.11%
H: 0.44%
C: -0.22%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 0.22%
H: 0.6%
C: 0.31%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: 0.19%
H: 0.25%
C: -0.28%
treatment global market
Global Nasal Drug Delivery Technology Market Projected to Reach $111.9 Billion by 2030
Published: 2023-08-23 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.41%
H: 1.07%
C: -1.39%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: -3.15%
H: 0.77%
C: 0.77%
PFE A | $25.69 -0.85% 0.1% 29M
|
Health Technology
|
| O: -0.5%
H: 0.45%
C: -0.86%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: -0.31%
H: 0.6%
C: -1.06%
ATR | $138.59 0.28% 0.0% 280K
|
Process Industries
|
| O: 0.08%
H: 1.6%
C: 1.31%
MMM | $91.05 -0.27% 0.31% 3M
|
Producer Manufacturing
|
| O: -0.38%
H: 1.41%
C: -0.78%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -0.39%
H: 0.46%
C: -1.37%
drug reach global technology market
Pharmacogenomics Industry Landscape 2023-2027: Personalized Medicine Propels Growth, Global Market Set for Robust Expansion
Published: 2023-08-22 (Crawled : 00:00) - prnewswire.com
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: 0.51%
H: 2.1%
C: 2.1%
QGEN | $39.32 -0.88% 0.0% 740K
|
Health Technology
|
| O: 0.25%
H: 1.26%
C: 0.92%
INFY | $17.05 -1.27% 0.0% 13M
|
Technology Services
|
| O: 0.53%
H: 1.23%
C: 1.11%
BIO | $292.75 -2.55% 0.0% 200K
|
Health Technology
|
| O: 0.25%
H: 1.63%
C: 1.56%
BDX | $231.01 -1.58% 0.0% 1.1M
|
Health Technology
|
| O: 0.11%
H: 0.0%
C: 0.0%
A | $136.8 -2.44% 0.0% 1.3M
|
Health Technology
|
| O: 0.23%
H: 0.54%
C: 0.52%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 1.73%
H: 0.0%
C: 0.0%
QGEN | $39.32 -0.88% 0.0% 740K
|
Health Technology
|
| O: 0.25%
H: 1.26%
C: 0.92%
MYGN F | $18.91 -1.36% -1.37% 480K
|
Health Technology
|
| O: 0.75%
H: 3.83%
C: 3.54%
ILMN | $117.66 -2.89% -2.97% 1.7M
|
Health Technology
|
| O: -1.47%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -0.16%
H: 0.79%
C: 0.64%
expansion global set market
Global Diabetes Drugs Market to Reach $106.65 Billion by 2028: Rising Prevalence of Diabetes Fuels Growth
Published: 2023-08-21 (Crawled : 16:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: 0.16%
H: 0.51%
C: 0.51%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 1.5%
H: 0.52%
C: 0.43%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -2.16%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 0.76%
H: 0.23%
C: -0.14%
reach global diabetes growth market
Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-08-14 (Crawled : 20:00) - globenewswire.com
DERM | $3.77 -6.22% -6.63% 120K
|
|
| O: -2.75%
H: 4.01%
C: -0.47%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: -1.75%
H: 0.0%
C: -2.23%
MBIO | $0.361 -3.73% -3.88% 360K
|
Health Technology
|
| O: 0.0%
H: 0.07%
C: -5.71%
FBIO | $1.79 -1.65% -1.68% 190K
|
Health Technology
|
| O: -8.92%
H: 0.0%
C: 0.0%
CKPT | $1.665 -3.2% -3.3% 510K
|
Health Technology
|
| O: -0.96%
H: 2.42%
C: -2.42%
ATXI | $0.1316 5.28% 5.02% 430K
|
Health Technology
|
| O: -2.37%
H: 4.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -1.27%
H: 0.26%
C: -0.61%
biotech financial results
Statkraft and AstraZeneca sign agreement on wind power delivery
Published: 2023-08-09 (Crawled : 07:00) - globenewswire.com
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 1.61%
H: 0.95%
C: 0.55%
agreement
Antithrombotic drugs market size to grow by USD 23,199.94 million from 2022 to 2027: The growing prevalence of coagulation disorders drives growth - Technavio
Published: 2023-08-09 (Crawled : 00:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.11%
H: 0.53%
C: 0.53%
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: 0.0%
H: 2.96%
C: 0.99%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -0.07%
H: 0.73%
C: 0.36%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.14%
H: 0.8%
C: 0.43%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 1.61%
H: 0.95%
C: 0.55%
disorders growing growth market
Fortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023
Published: 2023-08-03 (Crawled : 12:20) - globenewswire.com
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
FBIO | $1.79 -1.65% -1.68% 190K
|
Health Technology
|
| O: 1.2%
H: 1.52%
C: -4.99%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -2.88%
H: 1.68%
C: 1.53%
conference biotech
Global Adult Vaccine Market 2023: Rapid Growth in India with Increasing Awareness and Healthcare Measures
Published: 2023-07-28 (Crawled : 22:00) - prnewswire.com
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $135.94 -4.19% 770
|
Health Technology
| Email alert
Add to watchlist
SNYNF | $92.966 -2.18% 630
|
Health Technology
| Email alert
Add to watchlist
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
vaccine rapid india global growth market
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2-Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase II Trial
Published: 2023-07-27 (Crawled : 12:00) - biospace.com/
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 0.42%
H: 0.55%
C: -0.86%
enhertu tumors trial
ENHERTU® Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2 Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase 2 Trial
Published: 2023-07-27 (Crawled : 10:00) - biospace.com/
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 0.42%
H: 0.55%
C: -0.86%
enhertu her2 tumors trial
Tyrosine Kinase Inhibitors Market size to grow by USD 24.12 billion from 2022 to 2027 | High target affinity and specificity of tyrosine kinase inhibitors boost the market growth - Technavio
Published: 2023-07-26 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.38%
H: 2.49%
C: 2.49%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: -0.24%
H: 0.48%
C: -1.2%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.7%
H: 0.12%
C: -0.76%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 1.03%
H: 0.39%
C: -1.02%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 2.13%
H: 4.77%
C: 3.02%
PBYI | $5.1 -4.67% -4.9% 290K
|
Health Technology
|
| O: 0.28%
H: 0.85%
C: -1.99%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 0.42%
H: 0.55%
C: -0.86%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: -0.31%
H: 1.71%
C: 0.67%
growth market
Nanotechnology Drug Delivery Market to Reach $209.5 Billion, Globally, by 2032 at 9.1% CAGR: Allied Market Research
Published: 2023-07-19 (Crawled : 09:00) - prnewswire.com
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: 0.47%
H: 1.47%
C: 1.47%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.97%
H: 0.0%
C: 0.0%
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: 1.23%
H: 4.13%
C: 4.01%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.61%
H: 0.6%
C: -0.84%
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
|
| O: 0.19%
H: 1.19%
C: -0.1%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 1.5%
H: 0.75%
C: -0.32%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: 0.18%
H: 0.67%
C: -0.4%
drug reach research market
Text Analytics Market to grow at a CAGR of 19.82% from 2022 to 2027 | Alphabet Inc. Averbis GmbH Bitext Innovations SL Forsta AS Infegy InMoment Inc. and more to emerge as key players- Technavio
Published: 2023-07-14 (Crawled : 13:00) - prnewswire.com
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: 6.03%
H: -2.14%
C: -2.14%
SAPGF | $180.35 -19.46% 1.5K
|
Technology Services
|
| O: -0.34%
H: 1.8%
C: 1.29%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: 0.96%
H: 0.0%
C: -1.71%
SAP | $180.56 0.18% 0.0% 790K
|
Technology Services
|
| O: 0.06%
H: 0.6%
C: 0.22%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 0.24%
H: 0.44%
C: -0.06%
NICE | $231.46 -0.05% -0.05% 250K
|
Technology Services
|
| O: -0.01%
H: 0.96%
C: -1.5%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: -2.23%
GOOGL | $154.4 -0.3% -0.3% 21M
|
Technology Services
|
| O: 0.21%
H: 1.58%
C: 0.5%
GOOG | $155.98 -0.22% -0.22% 15M
|
Technology Services
|
| O: 0.24%
H: 1.57%
C: 0.46%
analytics market
Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio
Published: 2023-07-14 (Crawled : 11:00) - prnewswire.com
CSLLY | $89.5 3.3% 44K
|
n/a
|
| O: -0.54%
H: 0.0%
C: -1.4%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.0%
H: 1.42%
C: 0.96%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: 6.03%
H: -2.14%
C: -2.14%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: 0.96%
H: 0.0%
C: -1.71%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.03%
H: 0.2%
C: -0.8%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 0.24%
H: 0.44%
C: -0.06%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: -2.23%
pharma vaccine research market
American Red Cross Elects Aradhana Sarin as New Member to National Board of Governors
Published: 2023-07-13 (Crawled : 14:00) - prnewswire.com
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: -0.3%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 1.47%
H: 0.52%
C: 0.39%
Gene Therapy Company Genprex, Inc. (NASDAQ: GNPX) Receives Fast Track Designation From The FDA For Its Small Cell Lung Cancer Drug Candidate
Published: 2023-07-11 (Crawled : 14:00) - biospace.com/
GNPX | $2.29 -2.55% -2.62% 20K
|
Health Technology
|
| O: 1.25%
H: 3.41%
C: -1.43%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -0.28%
H: 0.25%
C: -0.23%
fda lung drug candidate cancer cell designation therapy fast track designation
Multiple Myeloma Drugs Market to grow by USD 6,419.94 million from 2022 to 2027|Growing incidence of multiple myeloma boosts the market growth - Technavio
Published: 2023-07-10 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.53%
H: 0.0%
C: 0.0%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.23%
H: 0.4%
C: 0.4%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.18%
H: 0.7%
C: 0.62%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.36%
H: 1.31%
C: 1.17%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 0.0%
H: 0.62%
C: 0.45%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -0.28%
H: 0.25%
C: -0.23%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: -0.4%
H: 0.78%
C: 0.01%
growth market
Acute Ischemic Stroke Therapeutics Market to grow by USD 1,524.49 million from 2022 to 2027|Rising prevalence of disease boosts the market - Technavio
Published: 2023-07-10 (Crawled : 19:00) - prnewswire.com
MDT | $79.25 -1.22% 0.0% 7.1M
|
Health Technology
|
| O: -0.15%
H: 1.17%
C: 1.12%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
BIIB | $195.16 -0.83% -0.85% 870K
|
Health Technology
|
| O: -0.56%
H: 0.19%
C: -0.06%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -0.28%
H: 0.25%
C: -0.23%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: -0.4%
H: 0.78%
C: 0.01%
disease stroke therapeutics market
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.